Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Analyst bearish on intermediate-risk TAVR uptake, but still sees market as positive
While transcatheter aortic valve replacement technologies are on target to becoming a $5 billion market by 2021, analysts believe the path to indications for intermediate risk patients may be slower than previously expected.
The market has showed a “notable step down in projected TAVR volume growth” in a set of surveys from April 2016 to Jan 2017, according to Leerink Partner analyst Danielle Antalffy. Read more
4. Amend Surgical wins FDA nod for NanoFuse BA bone graft extender
Amend Surgical said today that it won 510(k) clearance from the FDA to market its NanoFuse BA as a bone graft extender for spine and orthopedic indications.
The Alachua, Florida-based company’s NanoFuse BA is a composite of bioactive glass and a human demineralized bone matrix that Amend Surgical touts as providing optimal surgical handling performance and graft stability. Read more
3. Tandem claims 1st remote software update for insulin pump
Tandem Diabetes Care said today that it released a software update using the company’s Tandem Device Updater tool for its t:slim insulin pumps purchased before April 2015. It marks the 1st time an insulin pump manufacturer has provided a software update that employs customers’ personal computers.
The Mac and PC-compatible tool remotely overhauls Tandem’s insulin pump software, according to the company, and will update older insulin pumps to include an expansion of the reverse correction functionality, the ability to enter a manual bolus into the suggested bolus window, and off-pump cartridge filling. Read more
2. Tie forces 2nd Senate Finance vote on CMS nominee Verma
A tie vote yesterday by the U.S. Senate’s Finance Committee on Seema Verma, the nominee to head the Centers for Medicare & Medicaid Services, reportedly prompted the panel to schedule another ballot today.
The finance deadlocked at 9-9 yesterday on whether to pass Verma’s nomination on to the full Senate for a confirmation vote; the panel of 14 Republicans and 12 Democrats voted 15-11 with proxies to confirm, although the proxy votes do not count. The panel is due to vote again today, chairman Sen. Orrin Hatch (R-Utah) told Bloomberg. Read more
1. Study: Insurers paid double for hip and knee implants
Health insurers essentially paid double the price for hip and knee implants over a 5-year period, according to a study published this week in the Journal of the American Medical Assn.
Researchers at Boston’s Childrens Hospital culled statistics on total knee arthroplasties and total hip arthroplasties from the de-identified database of some 45 million patients belonging to a “nationwide, private health insurance plan,” according to the study. They culled claims data for 40,372 TKA patients and 23,570 THA patients from 2011 to 2015 and correlated that with average selling prices obtained from Orthopedic Network News and ECRI Institute’s PriceGuide. Read more
The post MassDevice.com +5 | The top 5 medtech stories for March 2, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2m0VEJD
Cap comentari:
Publica un comentari a l'entrada